Prelude Therapeutics - Delaware Business Times

Home Tags Prelude Therapeutics

Unsmudgeable Founder and CEO Swarna Shiv, left, holds an interviewing session with Troy Wilford of UD’s Horn Entrepreneurship program. Shiv and her company are on recipient of the Early Stage Growth Grant through The Innovation Space. | PHOTO COURTESY OF THE INNOVATION SPACE

Economic Development

Innovation Space’s new grant helps start-ups take next step

Katie Tabeling -

November 25, 2024

Dr. Milton Muldrow serves as director of Natural Sciences Programs at Wilmington University’s College of Health Professions and Natural Sciences. | PHOTO COURTESY OF WILMINGTON UNIVERSITY

Bioscience & Pharmaceutical

WilmU certificates to address biotech, forensic workforce needs

Jennifer Antonik -

October 11, 2024

Prelude Therapeutics

Bioscience & Pharmaceutical

Prelude signs a new partnership with pharma giant Merck

Katie Tabeling -

August 1, 2024

Prelude approved to receive state grant funds early

Bioscience & Pharmaceutical

Prelude approved to receive state grant funds early

Katie Tabeling -

May 3, 2024

Prelude Therapeutics

Bioscience & Pharmaceutical

Prelude Therapeutics finance officer departs

Katie Tabeling -

April 12, 2024

Delaware 222

Kris Vaddi

Guest Writer -

March 27, 2024

|Delaware Business Times Editor Katie Tabeling looks at the challenges many bioscience start-up companies face that seek to push boundaries in medical and scientific research.

Bioscience & Pharmaceutical

EDITORIAL: With a great vision, support, Delaware life sciences can thrive

Katie Tabeling -

March 11, 2024

|Delaware Business Times Editor Katie Tabeling looks at the challenges many bioscience start-up companies face that seek to push boundaries in medical and scientific research.

Bioscience & Pharmaceutical

Delaware biotech companies face ‘careful navigation’ to success

Katie Tabeling -

March 5, 2024

Bioscience & Pharmaceutical

Prelude Therapeutics cuts ribbon on new headquarters

Katie Tabeling -

February 9, 2024

Prelude Therapeutics CRISP Rendering 2

Bioscience & Pharmaceutical

Prelude Therapeutics raises $25M in share sale

Jacob Owens -

December 14, 2023

12 3 4 Page 1 of 4

Current Issue